by Rikki Almanza | Oct 7, 2026
The VA’s latest suicide prevention report found that most Veterans who died by suicide in 2024 had not recently received VA healthcare. The report––officially the 2026 National Veteran Suicide Prevention Annual Report––released on Sept. 30. examines national...
by Rikki Almanza | Aug 12, 2026
The VA has launched a clinical trial to study whether psilocybin can safely help Veterans with major depression that has not responded to conventional treatment, including those who also have PTSD. The study was announced Aug. 5 under the name Psilocybin Intervention...
by Rikki Almanza | Jul 27, 2026
California included $2 million in its 2026–27 budget to expand free legal services for Veterans pursuing military discharge upgrades. According to Gov. Gavin Newsom’s office, Veterans who were discharged due to trauma, injury, mental health issues, discrimination, or...
by Rikki Almanza | May 13, 2026
A new VA study found that Veterans who reported multiple toxic exposures during military service were more likely to experience suicidal thoughts and behaviors than Veterans who did not report exposures. The study, titled Toxic Exposure and Rates of Suicidal Thoughts...
by Rikki Almanza | Aug 14, 2024
The FDA recently denied a California-based drug company’s request to market MDMA, commonly known as ecstasy or molly, combined with talk therapy as a treatment for PTSD in Veterans. Lykos Therapeutics, located in San Jose, had submitted the application, which received...
